Explore Business Standard
Robotic surgery will be operational at the medical colleges in Hamirpur, Nerchowk in Mandi, and the IGMC in Shimla by January 2026, Himachal Pradesh Chief Minister Sukhvinder Singh Sukhu said in the Vidhan Sabha on Monday. In addition, smart labs are being established at Chamiyana and IGMC in Shimla and Tanda near Dharamsala, Sukhu said in a reply during the Question Hour, adding that the government is investing Rs 3,000 crore in the health sector. The state government aims to provide AIIMS Delhi-standard healthcare to its 7.5 million population. Patients in Himachal Pradesh are being charged on the lines of PGI Chandigarh, Sukhu said. Since the launch of robotic surgery in the state, 78 operations have been performed at Chamiyana, Shimla, and 38 at the Tanda Medical College, Kangra, in the past two months, he said. Responding to a supplementary question by BJP MLA Bikram Thakur, the chief minister said the training process for doctors is different, and funds are spent on the lines
West Bengal Chief Minister Mamata Banerjee on Monday said the state's flagship health assurance scheme, 'Swasthya Sathi', has crossed a significant milestone of one crore hospitalisations as of October 31. She said under the scheme, residents have received cashless medical treatment worth Rs 13,156 crore, fully funded from the state budget, she said. "Swasthya Sathi' -- the all-inclusive, unique health assurance scheme of Government of West Bengal has achieved one crore hospitalisations mark on 31st October 2025, where cashless health care benefit of Rs. 13,156 crore has been provided to the citizens of WEST BENGAL entirely from the State Budget," Banerjee posted on X. Highlighting the inclusivity of the initiative, the chief minister said that any resident of the state who is not covered under another state-sponsored health scheme is eligible for Swasthya Sathi benefits. "Any resident of West Bengal is eligible to avail the benefits of 'Swasthya Sathi', if not covered by any other
US Health Secretary Robert F Kennedy Jr, facing pointed bipartisan questioning at a rancorous three-hour Senate committee hearing on Thursday, tried to defend his efforts to pull back Covid-19 vaccine recommendations and explain the turmoil he has created at federal health agencies. Kennedy said the fired CDC director was untrustworthy, stood by his past anti-vaccine rhetoric, and disputed reports of people saying they have had difficulty getting Covid-19 shots. A longtime leader in the anti-vaccine movement, Kennedy has made sweeping changes to agencies tasked with public health policy and scientific research by laying off thousands of workers, firing science advisers and remaking vaccine guidelines. The moves -- some of which contradict assurances he made during his confirmation hearings -- have rattled medical groups and officials in several Democratic-led states, which have responded with their own vaccine advice. Medical groups and several Democrats in Congress have called for
Health products maker Cupid Ltd on Wednesday said it expects a revenue of more than Rs 100 crore to accrue from exports in the coming quarters. The international order book will be executed in the second and third quarters of 2025-26, the contraceptive products manufacturer said in a statement. The current B2B export order book is at USD 11.50 million which is equivalent to Rs 100 crore plus, across three key products segments," Cupid said in a statement. "These orders are from international government tenders in South Africa, Tanzania, and Kenya, as well as from international agencies WHO/UNFPA, NGOs like MSI and PSI," the company said. Cupid Ltd also anticipates significant orders from Brazil having secured L1 in the recent tender comprising 6.25 million pieces valued at approximately Rs 40 crore with additional future orders expected from that country, it said. The company also expects orders from Tanzania, one of the largest markets in East Africa, in Q2 and Q3 of FY26. These
Jim O'Neill, a top deputy to Health Secretary Robert F. Kennedy Jr., will serve as acting director of the Centers for Disease Control and Prevention, according to an administration official. The official requested anonymity to discuss a personnel change that has not been formally announced. The administration wants O'Neill to replace Susan Monarez, whom the White House is trying to remove only a month after starting the job. Monarez is fighting to keep her job. Her removal has left the nation's top public health agency reeling and three senior officials were escorted from its headquarters Thursday. The turmoil triggered rare bipartisan alarm as Kennedy tries to advance anti-vaccine policies that are contradicted by decades of scientific research. The chaos comes weeks before a key advisory committee, which Kennedy has reshaped with vaccine skeptics, is expected to meet to issue new recommendations on immunisations. Two Republican senators called for congressional oversight and som